Lung cancer company LUNGevity Foundation disclosed on Monday the promotion of Upal Basu Roy, PhD, MPH to vice president of its Research.
In the elevated position, Dr Basu Roy will manage the company's extensive educational library as well as lead the Translational Research programme, the Career Development Award programme, the research funded through the ALK Positive partnership and the Patient Focused Research Center – Patient FoRCe.
Previously, Dr Basu Roy led community-based participatory research (CBPR) methodology in health sciences research, projects involving immigrants and minority populations,led diabetes education for Asian immigrants in New York City as well as educated minority populations about breast cancer screening in Queens, NY.
The company added that Dr Basu Roy has a PhD in Molecular and Cellular Biology from the University of Arizona and an MPH in Global Health Policy and Management from New York University.
vTv Therapeutics secures USD51m private placement for cadisegliatin Phase 3 study
AbbVie names new chief executive officer
SkinBioTherapeutics expands foot care products in AMEA with Dermatonics partnership
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Insulet's Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus Sensor secures CE Mark approval
Kyowa Kirin enrols first subject in phase two tivozanib eye drops (KHK4951) clinical trial
China accepts GSK's Shingrix application for at-risk adults
Novo Nordisk to boost manufacturing capacity with acquisition of three fill-finish sites
Breye Therapeutics commences phase 1b/2a danegaptide clinical trial
DexCom Inc breaks ground on new manufacturing facility in Ireland
VibroSense Dynamics AB secures provisional patent for chemotherapy-induced nerve damage prediction
Innovent Biologics signs collaboration agreement with Sanegene Bio USA
Japan approves GSK's filing for Arexvy vaccination for at-risk adults